Bibliografia UJ CM




Zapytanie: KIM JIN SEOK
Liczba odnalezionych rekordów: 5



Przejście do opcji zmiany formatu | Wyświetl/ukryj etykiety | Wersja do druku | | | Nowe wyszukiwanie
1/5
Larry W. Kwak, Juan-Manuel Sancho, Seok-Goo Cho, Hideyuki Nakazawa, Junji Suzumiya, Gayane Tumyan, Jin Seok Kim, Tobias Menne, Jose Mariz, Nikolai Ilyin, Wojciech Jurczak, Aurelio Lopez Martinez, Olga Samoilova, Edvard Zhavrid, Eduardo Yanez Ruiz, Marek Trneny, Leslie Popplewell, Michinori Ogura, Won-Seog Kim, Sang Joon Lee, Sung Hyun Kim, Keum Young Ahn, Christian Buske.
Efficacy and safety of CT-P10 versus rituximab in untreated low-tumor-burden follicular lymphoma : final results of a randomized phase III study.
Clinical Lymphoma, Myeloma and Leukemia
2022 : Vol. 22, nr 2, s. 89-97, il., bibliogr. 24 poz., abstr.
Autor korespondencyjny: Christian Buske.
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.

p-ISSN: 2152-2650
e-ISSN: 2152-2669

AZ
ORG
AIF
IF: 2.700
Adres url:
Streszczenie w PubMed:
2/5
Christian Buske, Wojciech Jurczak, Juan-Manuel Sancho, Edvard Zhavrid, Jin Seok Kim, José-Ángel Hernández-Rivas, Aliaksandr Prokharau, Mariana Vasilica, Rajnish Nagarkar, Larry Kwak, Won-Seog Kim, SangJoon Lee, SungHyun Kim, KeumYoung Ahn, Michinori Ogura.
Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma : a randomized phase 3 study.
Blood Advances
2021 : Vol. 5, nr 17, s. 3354-3361, il., bibliogr. 20 poz.
Autor korespondencyjny: Michinori Ogura.
p-ISSN: 2473-9529
e-ISSN: 2473-9537

AZ
ORG
AIF
IF: 7.642
Adres url:
Streszczenie w PubMed:
3/5
Michinori Ogura, Juan Manuel Sancho, Seok-Goo Cho, H. Nakazawa, Junji Suzumiya, Gayane Tumyan, Jin Seok Kim, Anne Lennard, Jose Mariz, Nikolai Ilyin, Wojciech Jurczak, Aurelio Lopez Martinez, Olga Samoilova, Edvard Zharvid, Eduardo Yanez Ruiz, Marek Trneny, Leslie Popplewall, Bertrand Coiffier, Christian Buske, Won-Seog Kim, Sang Joon Lee, Sung Young Lee, Jun Ju Bae, Larry W. Kwak.
Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial.
Lancet. Haematology
2018 : Vol. 5, nr 11, s. e543-e553, il., bibliogr.
Autor korespondencyjny: Larry W. Kwak.
p-ISSN: 2352-3026

AZ
ORG
AIF
IF: 11.990
Adres url:
Streszczenie w PubMed:
DOI:
4/5
Won Seog Kim, Christian Buske, Michinori Ogura, Wojciech Jurczak, Juan-Manuel Sancho, Edvard Zhavrid, Jin Seok Kim, José-Ángel Hernández-Rivas, Aliaksandr Prokharau, Mariana Vasilica, Rajinish Nagarkar, Dzhelil Osmanov, Larry W. Kwak, Sang Joon Lee, Sung Young Lee, Yun Ju Bae, Bertrand Coiffier.
Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial.
Lancet. Haematology
2017 : Vol. 4, nr 8, s. e362-e373
Autor korespondencyjny: Bertrand Coiffier.
p-ISSN: 2352-3026

AZ
ORG
AIF
IF: 10.698
Adres url:
Streszczenie w PubMed:
DOI:
5/5
Shaji K. Kumar, Jae Hoon Lee, Meletios A. Dimopoulos, Evangelos Terpos, Efstathios Kastritis, Wee Joo Chng, Artur J. Jurczyszyn, Hiroshi Handa, Shuji Ozaki, Xavier Leleu, Philippe Moreau, Juan José Lahuerta, Chaim Shustik, Daniel Dirck Waller, Meral Beksac, Ravi Vij, Kihyun Kim, Jin Seok Kim, Ashraf Z. Badros, Melissa Alsina, Brian G.M. Durie.
Outcomes after Initial Relapse of Multiple Myeloma: An International Myeloma Working Group Study.
Blood
2015 : Vol. 126, nr 23, abstr. 4201
57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL, DEC 05-08, 2015.
p-ISSN: 0006-4971

SZZ
SIF
Adres url:
  Wyświetl ponownie stosując format:
Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ